Clostridioides difficile (C. diff) is a stealthy threat. It infects more than 500,000 people in the United States each year, ...

After nearly two weeks of improbable wins, Victoria Mboko meets four-time Grand Slam champion Naomi Osaka in the Montreal final (6 p.m. ET). Here's why both players can win.

Although washing your hands with soapy water in the plane toilet might sound like a good idea, a microbiologist has revealed ...

Pfizer's beleaguered obesity strategy has hit another setback as the pharma jettisoned its third and final GLP-1 agonist, ...

Recursion Pharmaceuticals stock drops as Q2 loss widens and pipeline shake-up continues, despite revenues boost from Sanofi ...

C. diff, which is short for Clostridioides difficile, is a type of bacteria that may cause serious problems in the digestive ...

TUESDAY, August 5, 2025 (HealthDay News) — C. diff, which is short for Clostridioides difficile, is a type of bacteria that ...

Novavax posted a surprise profit in Q2 2025, reporting GAAP EPS of $0.62 compared to an expected loss of $0.04 per share. Revenue (GAAP) was $239 million, well above the analyst estimate of $152.61 ...

Probiotics were favored over placebo for CDI prevention, particularly with twice-daily dosing, but their overall effect on disease incidence was not significant.

When bacterial pathogens enter our bodies, they've got one goal-hunt for food to multiply. And during the process, they make us sick. Inside the Skaar ...

RXRX eyes Q2 earnings beat despite past misses, with a refocused pipeline and new data updates on key drug candidates.